Legal & General Group
RAPP

Legal & General Group’s Rapport Therapeutics RAPP Stock Holding History

Legal & General Group’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$537K Sell
17,154
-5,230
-23% -$147K ﹤0.01% 2338
2025
Q4 		$679K Sell
22,384
-11,509
-34% -$319K ﹤0.01% 2333
2025
Q3 		$1.01M Buy
33,893
+32,240
+1,950% +$575K ﹤0.01% 2237
2025
Q2 		$18.8K Sell
1,653
-8,643
-84% -$91.7K ﹤0.01% 3032
2025
Q1 		$103K Buy
10,296
+773
+8% +$10K ﹤0.01% 2664
2024
Q4 		$169K Buy
9,523
+8,614
+948% +$191K ﹤0.01% 2681
2024
Q3 		$18.6K Buy
+909
New +$19.5K ﹤0.01% 3080

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return